Inactive

Renin Levels in Recurrent By M.A.

Johnston,

R. Carachi,

@A prospective study of four children with nephroblastoma has demonstrated elevation of plasma inactive renin levels at the time of detection of recurrent disease. Three of the four children had been shown to have elevated inactive renin levels at their initial presentation with primary nephroblastoma. These levels returned to normal following operation and chemotherapy. The observation provides further evidence that plasma inactive renin may be a useful tumour marker for nephroblastoma. Copyright o 1991 by WA Saunders Company

G.B.M.

Lindop,

Nephroblastoma and B. Leckie ACTIVE

TOTAL

10,000

1

i lvooo: 2 2

A*

.E

At

5E 100

A A

:A

\

31

INDEX WORDS:

INACTIVE

.

Inactive renin; recurrent nephroblastoma. 10

I

T IS WELL established that a variety of tumours, mainly renal, may secrete renin. Of the 50 patients with these tumours so far described, 40 had nephroblastoma.‘,’ It is now known that the elevation in plasma renin levels is due to a preponderance of the prohormone inactive renin.2*3 This raised the possibility that inactive renin may be of value as a chemical tumour marker for nephroblastoma. We report our experience with plasma renin levels in nephroblastoma patients with recurrent or metastatic disease. MATERIALS

AND

METHODS

At this centre, children with nephroblastoma are managed according to the UK Cancer Children’s Study Group guidelines. At presentation, blood is routinely taken for total plasma renin estimation. This is repeated following initial treatment and again if there is clinical suspicion of recurrent disease. Total plasma renin estimation: 3 mL of blood were place in a lithium heparin tube and kept in ice during transport to the renin laboratory, where the plasma was extracted and stored at -20°C. Twenty microlitres of a 10 mg/mL solution of trypsin was added to 200 uL of ice-cold plasma. This was incubated at 4°C for 3 to 6 minutes. Twenty microlitres of soya bean trypsin inhibitor (20 mg/mL) was added. The renin assay was then carried out, measuring the active and inactive components by microassay as described by Millar et aL4 RESULTS

From 1984 to 1989, a total of 25 children were treated for nephroblastoma. Of these, four children have been identified with recurrent disease (Table 1). One patient had chromosome fragility disease and another presented following a road traffic accident. The mean plasma renin levels for all nephroblastoma patients decreased after tumour excision (Fig l), and subsequently became elevated in the four patients found to have recurrent disease (Table 2, Fig 2). DISCUSSION

The role of the renin-angiotensin system in children with nephroblastoma has been studied prospecJournalof Pediatric Surgery, Vol26,

No 5 (May), 1991: pp 613-614

I

OJ

Pre

Post

Pre

Post

Pre

Post

Fig 1. Mean total, active, and inactive renin levels, preoperation and postoperation for all patients with nephroblastoma. A, Patients with recurrent disease.

tively by several authors.‘U3 High levels of inactive renin were reported, which fell to normal levels after complete removal of the tumour.’ High levels of active renin have been reported in a hypertensive child with a juxtoglomerular secreting tumour.5 Active renin was also found to be elevated in neuroblastoma, in contrast to the inactive renin component.’ The criteria for a tumour marker to be established are that the substance must be readily assayable; it must be sensitive and specific for the tumour type; the levels must return to normal following adequate treatment; and elevation must correlate with clinically detectable recurrent disease. We have followed-up the initial cohort of patients reported by us.* Of the four patients who developed recurrent disease, one had an abdominal recurrence, another had cerebral metastases, and two had recurrent disease in the mediastinum and lungs. In all these patients the plasma renin levels were elevated and,

From the Depattment of Surgical Paediattics, Royal Hospital for Sick Children, the Department of Pathology, University of Glasgow, and the h4RC Blood Pressure Unit. Western Infirmary. Glasgow, Scotland. Presented at the 37th Annual International Congress of the British Association of Paediatric Surgeons, Glasgow, Scotland, July 25-27, 1990. Address reprint requests to R. Carachi, MD, PhD, FRCS, Department of Surgical Paediattics, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8U, Scotland. Copyright o 1991 by W B. Saunders Company 0022-3468/9112605-0027$03.OOfO

613

JOHNSTON

614

ET AL

Table 1. Patients With Recurrent Disease Stage, Histology

Disease Case No.

Age at

Presentation

1

1 vr

2

2 vr

3 4

Operation Nephrectomy (R), partial hepatectomy

Intervalto

Site of Recurrent

Disease

FldapSe

Brain

Outcome

II, favourable

Died, metastases

4 vr

Nephrectomy (R)

II, favourable

4 vr

Lung

Died, metastases

4 vr

Nephrectomy (L)

II, favourable

Mediastinum

Alive, disease-free

5 vr

Emergency nephrectomy (R)

Ill, favourable

2 vr 18mo

Intraabdominal, lung

Died, metastases

Abbreviations: R, right; L, left.

Table 2. Plasma Renin Levels for the Four Patients With Recurrent Disease Renin Levels Total

Active

Inactive

Measurement

(60-200)

(9-50)

(38.180)

Presentation

2,090

Time of Case No.

1

2

3

4

(WlJlmL)

2,205

115

Postoperation

140

58

82

Recurrence

738

186

552

2,980

285

2,695

Postoperation

266

85

181

Recurrence

288

85

195

Presentation

920

170

750

Presentation

Postoperation

118

15

103

Recurrence

353

41

312

No preoperative values obtained

Presentation Postoperation

140

59

81

Recurrence

955

278

677

pU/ml 3000 12695 2000

1 1000

800

600

Fig 2. Plasma inactive renin levels (A) preoperation, (6) postoperation, and (C) at the time of detection of recurrent disease.

therefore, would be of value as a tumour marker. Clinical disease was also present at the time that the elevated inactive renin levels were measured and, therefore, we cannot establish whether this elevation antedated the appearance of clinically detectable disease. The role of inactive renin in recurrent nephroblastoma warrants further investigation because if serial estimations are performed, the outlook for early detection of recurrent disease may improve. We recommend that once a patient with nephroblastoma has completed treatment, plasma inactive renin levels should be estimated as part of their follow-up. REFERENCES 1. Guademar M, Bruneval P, Camilleri JP: Syndromes tumoraux avec secretion inappropriee de renine. Criteres diagnostiques et revue des cas publies. Ann Path01 8:83-90, 1988 2. Carachi R, Lindop GBM, Leckie BJ: Inactive renin: A tumour marker in nephroblastoma. J Pediatr Surg 23:278-280,1987 3. Day RP, Luetscher JA: Big renin: A possible prohormone in kidney and plasma of a patient with Wilm’s tumour. J Clin Endocrinol Metab 38:926-928,1974 4. Millar JA, Leckie BJ, Morton JJ, et al: A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chin Acta 1015-15. 1980 5. Khan AB, Carachi R, Lindop GBM, et al: Hypertension associated with increased renin levels in Nephroblastoma. Arch Dis Child (in press) 6. Leckie BJ, Carachi R, Wheldon T, et al: Plasma renin levels in patients with thoracic neuroblastoma. J Pediatr Surg 24:602-603, 1989

Inactive renin levels in recurrent nephroblastoma.

A prospective study of four children with nephroblastoma has demonstrated elevation of plasma inactive renin levels at the time of detection of recurr...
201KB Sizes 0 Downloads 0 Views